Additive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteins
about
Brief History and Characterization of Enhanced Respiratory Syncytial Virus DiseaseRespiratory syncytial virus-like nanoparticle vaccination induces long-term protection without pulmonary disease by modulating cytokines and T-cells partially through alveolar macrophages.Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.The Respiratory Syncytial Virus Phosphoprotein, Matrix Protein, and Fusion Protein Carboxy-Terminal Domain Drive Efficient Filamentous Virus-Like Particle Formation.Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model.Novel therapies and vaccines against the human respiratory syncytial virus.Respiratory syncytial virus vaccines: an update on those in the immediate pipeline.A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.Soluble F proteins exacerbate pulmonary histopathology after vaccination upon respiratory syncytial virus challenge but not when presented on virus-like particles.Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats.Virus-like particle vaccine by intranasal vaccination elicits protective immunity against respiratory syncytial viral infection in mice.Cellular Immune Correlates Preventing Disease Against Respiratory Syncytial Virus by Vaccination with Virus-Like Nanoparticles Carrying Fusion Proteins.
P2860
Q26775152-643AD973-E90B-45B2-BE9E-D602C922FF5DQ35867712-DD34DD66-1721-4E7A-9CCE-350D5BD13027Q36281893-F9FACC09-1DB3-4EF3-86D4-A2D897CE5C7AQ37415410-43277188-DEDF-4C02-8861-4AE46C1F7014Q37635077-A654B01D-46D5-4F7C-81AB-ABA782053D92Q38604787-AD4C3EBC-FB3E-4402-A30D-95D2D8723DBAQ38803541-38C2A468-61F4-4551-9EC0-AFA4489B3B59Q38905050-FD2001FC-C47F-4540-9993-8163144970EDQ40065136-8B744478-A9CF-4632-B957-BB7449805A9FQ40355982-9510F8E2-0F31-4447-9AF6-154E9F116022Q40409972-11814B30-84DE-4D3E-AE40-2E1B53A1AEA9Q47137183-0FAFB41F-7F6D-4EFB-8EDC-468CF51CD5EB
P2860
Additive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteins
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Additive protection induced by ...... on or attachment glycoproteins
@ast
Additive protection induced by ...... on or attachment glycoproteins
@en
Additive protection induced by ...... on or attachment glycoproteins
@nl
type
label
Additive protection induced by ...... on or attachment glycoproteins
@ast
Additive protection induced by ...... on or attachment glycoproteins
@en
Additive protection induced by ...... on or attachment glycoproteins
@nl
prefLabel
Additive protection induced by ...... on or attachment glycoproteins
@ast
Additive protection induced by ...... on or attachment glycoproteins
@en
Additive protection induced by ...... on or attachment glycoproteins
@nl
P2093
P2860
P1433
P1476
Additive protection induced by ...... on or attachment glycoproteins
@en
P2093
Fu-Shi Quan
Kaori Sakamoto
Martin L Moore
Richard W Compans
Sang-Moo Kang
Youngman Kwon
P2860
P304
P356
10.1016/J.ANTIVIRAL.2014.09.005
P577
2014-09-18T00:00:00Z